160
Participants
Start Date
February 2, 2023
Primary Completion Date
May 30, 2024
Study Completion Date
June 10, 2024
Control group
Participants receive supplement prescriptions from a physician based on current standard practices, which include biochemical markers, genetic data, and metabolic profiles.
AI-Guided Group
Participants receive supplement prescriptions determined by GenAIS, an AI system which considers genetic data, metabolic profiles, biochemical markers, and patient history.
Center of New Medical Technologies, Novosibirsk
Collaborators (1)
Triangel Scientific
INDUSTRY
Center of New Medical Technologies
OTHER
S.LAB (SOLOWAYS)
OTHER